Nanōmix (Emeryville, CA) is a leading nanoelectronic detection company. It develops point-of-care devices based on its proprietary Sensation™ technology—the first universal detection platform offering unprecedented sensitivity that provides central lab-quality performance at the site of patient care. With more than 20 issued and pending patents and numerous awards that recognize its innovative technology, today Nanōmix is poised to become the premier provider of analytical detection devices for the next generation of rapid point-of-care (POC) diagnostics. Nanōmix was founded in 2000 as a Berkeley Lab spinout to commercialize proprietary nanotechnology for detecting a wide variety of biological molecules and gases for disease management, industrial process control, and the detection of pollutants in air and water. More information is available at http://www.nano.com.
Corgenix and Nanōmix are collaborating on adapting some of the Corgenix assays to the Nanōmix carbon nanotube (CNT) technology.